Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jérôme Marijsse"'
Autor:
Matteo Rossi, Mikhail Steklov, Fanny Huberty, Thuy Nguyen, Jérôme Marijsse, Céline Jacques-Hespel, Paul Najm, Caroline Lonez, Eytan Breman
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 34, Iss , Pp 102038- (2023)
Genome engineering technologies are powerful tools in cell-based immunotherapy to optimize or fine-tune cell functionalities. However, their use for multiple gene edits poses relevant biological and technical challenges. Short hairpin RNA (shRNA)-bas
Externí odkaz:
https://doaj.org/article/6612d3e5f3c04f28ab6f4e335c57c900
Autor:
Eytan Breman, Benjamin Demoulin, Sophie Agaugué, Sebastien Mauën, Alexandre Michaux, Lorraine Springuel, Julien Houssa, Fanny Huberty, Céline Jacques-Hespel, Céline Marchand, Jérôme Marijsse, Thuy Nguyen, Nancy Ramelot, Benjamin Violle, Dorothée Daro, Peter De Waele, David E. Gilham, Valérie Steenwinckel
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Chimeric Antigen Receptor (CAR) T cells expressing the fusion of the NKG2D protein with CD3ζ (NKG2D-CAR T Cells) acquire a specificity for stress-induced ligands expressed on hematological and solid cancers. However, these stress ligands are also tr
Externí odkaz:
https://doaj.org/article/3a89e9c594694720a2cb44b8f7218adf
Autor:
Benjamin Violle, Céline Jacques-Hespel, Nancy Ramelot, Fanny Huberty, Eytan Breman, Peter De Waele, Sébastien Mauen, Alexandre Michaux, Lorraine Springuel, Benjamin Demoulin, Jérôme Marijsse, Thuy Nguyen, Céline Marchand, Dorothée Daro, Valérie Steenwinckel, Sophie Agaugue, David E. Gilham, Julien Houssa
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology
Frontiers in Immunology
Chimeric Antigen Receptor (CAR) T cells expressing the fusion of the NKG2D protein with CD3ζ (NKG2D-CAR T Cells) acquire a specificity for stress-induced ligands expressed on hematological and solid cancers. However, these stress ligands are also tr
Autor:
Thủy Nguyễn, Matteo Rossi, Eytan Breman, Fanny Huberty, Celine Jacques-Hespel, Jerome Marijsse
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f4456118363a434f9b877d0ddb7d9b2d
Autor:
Thủy Nguyễn, Sophie Agaugué, Caroline Lonez, Eytan Breman, Benjamin Violle, Jennifer Bolsee, Jerome Marijsse
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/6fe501dc38a34959988ebd2b5ff199ba
Autor:
Thủy Nguyễn, Matteo Rossi, Eytan Breman, Fanny Huberty, Celine Jacques-Hespel, Jerome Marijsse
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/bc3924b8aad24487b22eeda38859bd94
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/770152f1e0f44bdcbb3d9c032beebd12
Autor:
David E. Gilham, Thuy Nguyen, Julien Houssa, Céline Jacques-Hespel, Eytan Breman, Sophie Agaugue, Jennifer Bolsée, Fanny Huberty, Nancy Ramelot, Céline Marchand, Jérôme Marijsse, Benjamin Violle
Publikováno v:
Cancer Research. 78:3583-3583
Chimeric antigen receptor (CAR) protein are artificial protein created by the fusion of an extracellular domain targeting one or several cell surface antigens, a transmembrane domain and an intracellular domain responsible for signal initiation and t
Autor:
Simon Bornschein, Thuy Nguyen, Céline Jacques-Hespel, Susanna Raitano, Fanny Huberty, Céline Marchand, Jennifer Bolsée, Jérôme Marijsse, Benjamin Violle, Nancy Ramelot, Julien Houssa, David E. Gilham, Sophie Agaugue
Publikováno v:
Journal of Clinical Oncology. 36:e15040-e15040
e15040Background: The majority of CAR-T cell therapy studies use the patients’ own autologous cells which carry many potential restrictions related to manufacturing such as quantity and quality of ...
Autor:
Céline Jacques-Hespel, Sophie Agaugue, Nancy Ramelot, Julien Houssa, David E. Gilham, Jennifer Bolsée, Eytan Breman, Sébastien Mauen, Benjamin Violle, Céline Marchand, Alexandre Michaux, Thuy Nguyen, Jérôme Marijsse, Fanny Huberty
Publikováno v:
Journal of Clinical Oncology. 36:e15042-e15042
e15042Background: Most CAR T cell therapy relies on autologous cells with potential limitation in quality of the cells. Cells derived from an allogeneic healthy donor may be more consistent in qual...